SCHOENBERG MARK (Chief Medical Officer) sold 3.3% of their position (5.16K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $38.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/11/2025ACC: 0001437749-25-020045
Officer· Chief Medical Officer
Since Jan 2019
-5.16K
Net shares
Net seller
$38.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 15.16K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
6.7%
6/8/2025
148.54K→158.54K
Ordinary Shares
Direct
Shares
−5.16K
Price / share
$7.37
Trade value
$38.04K
% of position
3.3%
6/9/2025
158.54K→153.38K
Total
Net shares
+4.84K
Net value
-$38.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/8/2025 | M · Option Exercise | +10K | — | — | 6.7% | 148.54K | 158.54K |
| Ordinary Shares Direct | 6/9/2025 | S · Sale | −5.16K | $7.37 | $38.04K | 3.3% | 158.54K | 153.38K |
| Total | +4.84K | -$38.04K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
10K shares
Shares
−10K
Strike price
Held after
10K
Exercisable
—
6/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares10K shares | 6/8/2025 | M · Option Exercise | −10K | — | 10K |